source
- Draig Therapeutics secures $65M Series B to advance brain-drug trialsDraig Therapeutics announced a $65 million Series B financing led by Deep Track Capital, with participation from Janus Henderson Investors, Marshall Wace and other investors. The capital will fund…
- Former FDA toxicologist says agency approved Zyn nicotine pouches without fully knowing their compositionFormer FDA toxicologist Christy Leppanen alleges the agency authorized Zyn nicotine pouches without complete safety data on the pouch material. Leppanen, who led a microplastics exposure project a…